Reglagene, LLC
TUCSON, AZ · Founded 2018 · CIK 0001747083 · Biotech · Private
Brain-penetrant small molecule therapeutics for neurological diseases
reglagene.com →- Grants
- $702K
- 2 awards
- Sector median: 1
- Raised
- $1.9M
- 4 Form D · May 2024
- 29 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $546,413 | |
| Federal grant | Department of Health and Human Services · Phase I · DNA Quadruplex Control of hTERT Transcription: A New Therapy for Taxotere Resistant Prostate Cancer | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Glioblastoma multiforme therapy via telomerase reverse transcriptase (hTERT) down-regulation. Molecular chaperones redirect quadruplex folding to reverse the effect of hTERT gene promoter mutations. | $401,714 | |
| Private capital raised | Form D · SEC | $600,000 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Private capital raised | Form D · SEC | $766,655 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1603 | Acer Therapeutics Inc. | — | $8.2M |
| 1604 | CeleCor Therapeutics, Inc. | — | $3.7M |
| 1605 | THERALINK TECHNOLOGIES, INC. | — | $2.6M |
| 1606 | Reglagene, LLC | — | $1.9M |
| 1607 | XenoTherapeutics Corp | — | $1.3M |
| 1608 | RIBO-THERAPEUTICS LLC | — | — |
| 1609 | Yuva Biosciences, Inc. | — | $1.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard AustinDirector · Executive Officer
- Sharon AydDirector
- David BearssDirector
- Laurence HurleyDirector
- Lawrence KinetDirector
- Ayd SharonDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.